Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05752253

Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.

Conditions: Hereditary Hemorrhagic Telangiectasia

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 50
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Location: Italy

Summary

The goal of this interventional study is to determine the incidence of depression, anxiety, sleep disturbances and resilience in a sample of subjects affected by Hereditary Hemorrhagic Telangiectasia. The study is declined through the evaluation of some outcome parameters at the time of enrollment (T0), during the counseling intervention (T1 and T2) and at the end (T3) of the subjects who will have carried out an individual counseling intervention.

Eligibility Criteria

Inclusion Criteria:Recruited subjects have a diagnosis of Hereditary Hemorrhagic Telangiectasia and are 18 years of age or older.Exclusion Criteria:Previous or current intellectual disability and a diagnosis of psychiatric disorders in accordance with the Diagnostic and Statistical Manual of Mental Disorders, DSM-5.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05752253). StuddyBuddy aggregates publicly available trial information.